Lantheus News

Lantheus Holdings Analyst Ratings

BenzingaApr 18 13:14 ET

Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Johnson & Johnson (JNJ) and Lantheus (LNTH)

TipRanksApr 18 00:30 ET

Buy Rating for Lantheus Holdings With Strong Growth and Acquisition Potential

TipRanksApr 17 20:16 ET

Buy Rating on Lantheus Holdings Amid Overlooked Pylarify Growth and Market Expansion Opportunities

TipRanksMar 6 20:25 ET

Truist Securities Reiterates Buy on Lantheus Holdings, Raises Price Target to $82

BenzingaFeb 26 08:23 ET

Lantheus Holdings Analyst Ratings

BenzingaFeb 26 08:22 ET

Truist Financial Sticks to Its Buy Rating for Lantheus (LNTH)

TipRanksFeb 26 07:16 ET

Lantheus Holdings: Strong Buy on Robust Q4 Earnings and Promising Growth Prospects

TipRanksFeb 25 23:25 ET

Lantheus Holdings Analyst Ratings

BenzingaFeb 23 12:34 ET

Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Lantheus (LNTH) and Ardelyx (ARDX)

TipRanksFeb 23 08:40 ET

Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH) and Evolent Health (EVH)

TipRanksFeb 23 00:40 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Moderna (MRNA) and Lantheus (LNTH)

TipRanksFeb 22 12:50 ET

Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH), Incyte (INCY) and Fusion Pharmaceuticals (FUSN)

TipRanksFeb 15 01:20 ET

Stable Transition and Strategic Continuity Justify Buy Rating for Lantheus Holdings

TipRanksJan 26 00:46 ET

Buy Rating Affirmed for Lantheus With Leadership Transition and Strategic Oncology Focus

TipRanksJan 26 00:36 ET

Buy Rating Affirmed for Lantheus: Strategic Leadership and Strong Financials Signal Growth

TipRanksJan 23 10:56 ET

Analysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Roche Holding AG (OtherRHHVF)

TipRanksJan 15 14:20 ET

Lantheus: A Buy Rating Based on Strategic Growth and Diversified Radiopharmaceutical Pipeline

TipRanksJan 11 15:35 ET

Leerink Partners Sticks to Its Buy Rating for Lantheus (LNTH)

TipRanksJan 11 01:41 ET

B. Riley Lowers Lantheus Holdings' Price Target to $95 From $113, Keeps Buy Rating

MT NewswiresJan 10 08:15 ET